The Association between Visit-to-Visit Variability of Blood Pressure and the Risk of Metabolic Syndrome: The Moderating Effect of Weight

Abstract

Aims. Metabolic syndrome (MetS) affects approximately one-third of the global population. Visit-to-visit variability of blood pressure (VVV-BP) constitutes a substantial risk factor for numerous chronic conditions. Thus, this study aimed to assess the relationship between VVV-BP and MetS and identify potential moderating factors between these. Methods. Data were obtained from the China Health and Retirement Longitudinal Study, a nationally representative study. Multiple logistic regression analyses were utilized to explore the association between VVV-BP and MetS while incorporating moderation analyses. MetS was defined according to the criteria outlined in the Joint Interim Statement. VVV-BP was expressed by the standard deviation, coefficient of variation, average real variability, and root mean square error. Results. Individuals with the highest levels of VVV of systolic blood pressure (SBP) exhibited a 70% increased risk of MetS compared to those with the lowest levels (OR = 1.70, 95% CI = 1.31–2.21). In addition, they had a 41% increased risk of VVV of diastolic blood pressure (DBP) (OR = 1.41, 95% CI = 1.09–1.81). Notably, weight change status significantly influenced the relationship between VVV-BP and MetS (Pinteraction = 0.01). Conclusions. VVV-BP is a significant contributor to the risk of developing MetS. Importantly, individuals who experienced weight loss during the follow-up period did not face a significantly higher risk of developing MetS.